Remove 2022 Remove Advocacy Remove State Laws Remove Treatment
article thumbnail

MAPS – Position: State Government Affairs Lead – Remote

Cannabis Law Report

MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

article thumbnail

Every Missouri Dispensary That MMJ Patients Need To Know

MMJ Recs

As of August 2022, 213 medical marijuana dispensary licenses had been granted in Missouri, and out of these, 197 are operational and open for business. MMJ treatment has proved very popular with Missourians and there has turned out to be a huge demand for medical marijuana products in the Show Me State. Tourette syndrome.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Andrew Easto – Barbuto v. Advantage Sales and Marketing

Cannabis Law Report

For the third category, the Court recognized transportation employers, federal government contractors, and recipients of federal grants as employers with such statutory obligations under federal law. The plaintiff, Cristina Barbuto, used small quantities of medicinal marijuana as treatment for her Crohn’s disease. Barbuto v.

Policy 52
article thumbnail

Americans for Safe Access (ASA) has released a report examining the efficacy of state medical cannabis laws.

Cannabis Law Report

“With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It ASA examines medical cannabis law efficacy. TOP FIVE KEY TAKEAWAYS FROM THE 2021 STATE OF THE STATES REPORT.

Access 98
article thumbnail

Rhode Island House Greenlights Psilocybin Legalization, Paving the Way for Therapeutic Access

Veriheal

If approved by the Food and Drug Administration (FDA), this psychedelic would be used to treat chronic and life-threatening mental disorders, especially for patients with limited access to effective treatments. Federal laws currently classify psilocybin as a Schedule I drug alongside addictive drugs like cocaine and fentanyl.

Access 97
article thumbnail

Oregon Cannabis Legislative Preview: Producer Moratorium, Equity, State Banking and More

Cannabis Law Report

If this bill passes, the OLCC and ODA will INACTIVATE all marijuana producer and hemp grower applications received after January 1, 2022. The OLCC did, however, release a bulletin on November 8, 2021, announcing that the agency would no longer inactivate new producer applications beginning on January 2, 2022.

Banking 52